logo
gategroup Successfully Prices Refinancing Transaction, Paving the Way for Growth and Market Expansion

gategroup Successfully Prices Refinancing Transaction, Paving the Way for Growth and Market Expansion

Yahooa day ago

gategroup Holding AG ('gategroup') is pleased to announce the successful pricing of its comprehensive refinancing package, comprising two term loans of EUR 675 million and USD 500 million, both with a tenure of 7 years, and a CHF 300 million multicurrency revolving credit facility (the 'new financing') with a tenure of 6.5 years. The transaction was significantly oversubscribed and priced at the tighter end of guidance - strongly underscoring market confidence in gategroup's strategy and performance.
This transaction represents gategroup's debut as a Term Loan B (TLB) issuer, and the company is pleased to have attracted strong demand from leading global institutional investors. The level of interest received highlights the trust placed in gategroup's credit profile, operational resilience, and future growth potential.
The New Financing is backed by a syndicate of top-tier global financial institutions and supports the refinancing of existing loans, notably the EUR 250 million Term Loan A and the CHF 415 million revolving credit facility, while also improving liquidity and flexibility.
'This successful refinancing marks a pivotal milestone for us,' said Christoph Schmitz, Chief Executive Officer of gategroup. 'The broad-based support from a large group of premier banking partners and top global funds is a powerful endorsement of our business and strategy. This transaction diversifies gategroup´s funding base and allows us to invest in long-term initiatives, expand our global footprint, and further elevate our market-leading services in airline catering and hospitality.'
With the anticipated upgrade in its corporate credit rating to B2 (stable) / B+ (stable) by Moody's and S&P Global respectively, gategroup gains improved access to capital markets. The refinancing significantly enhances the company's capital structure and positions it for sustainable growth and value creation.
Urs Schwendinger, Chief Financial Officer of gategroup, added: 'We are extremely pleased with the outcome of this transaction, which despite volatile market conditions has achieved several notable milestones among deals launched post-the US tariff announcements, including the largest cross-border loan issuance, largest debut issuance, and in its segment and rating universe, the largest new money loan deal and the largest Swiss issuance.'For media and investor inquiries, please contact:
IR@gategroup.com
mediacontact@gategroup.com
About gategroup
gategroup is the global leader in airline catering, retail-on-board, and hospitality products and services. Headquartered in Zurich, Switzerland, gategroup operates over 200 units in more than 60 countries, delivering culinary and retail excellence to passengers across all continents. Learn more at www.gategroup.com.gategroup schließt Refinanzierung erfolgreich ab und ebnet den Weg für weiteres Wachstum und Marktexpansion
Die gategroup Holding AG ('gategroup') freut sich, den erfolgreichen Abschluss und die Preisfestsetzung ihres umfassenden Refinanzierungspakets bekannt zu geben. Die neue Finanzierung umfasst zwei Term Loan B Instrumente in Höhe von EUR 675 Mio. und USD 500 Mio., beide mit einer Laufzeit von 7 Jahren, und eine revolvierende Kreditfazilität in Höhe von CHF 300 Mio. mit einer Laufzeit von 6,5 Jahren (die 'Neue Finanzierung'). Die Transaktion war deutlich überzeichnet und wurde zu attraktiven Konditionen abgeschlossen, was das Vertrauen der Märkte in gategroups Strategie und finanzielle Stärke unterstreicht.
Mit dieser Emission tritt gategroup erstmals als Term Loan B Emittentin auf, und das Unternehmen freut sich über die starke Nachfrage von führenden globalen institutionellen Investoren. Das große Interesse unterstreicht das Vertrauen in gategroups Marktposition, die operative Leistungsfähigkeit und das zukünftige Wachstumspotenzial.
Die Neue Finanzierung wird von einem Konsortium erstklassiger internationaler Finanzinstitute unterstützt und dient der Refinanzierung bestehender Kredite, insbesondere des EUR 250 Mio. Term Loan A und der existierenden revolvierenden Kreditfazilität in Höhe von CHF 415 Mio. Sie verbessert gleichzeitig die Liquidität und Flexibilität der Gruppe.
'Diese erfolgreiche Refinanzierung ist ein entscheidender Meilenstein für uns', sagt Christoph Schmitz, Chief Executive Officer von gategroup. 'Die breite Unterstützung durch eine große Gruppe führender Bankenpartner und globaler Top-Fonds sind ein starkes Signal für unser Geschäft, unsere Kunden und unsere Strategie. Die Transaktion schafft neue Optionen und ermöglicht es uns in langfristige Projekte zu investieren, unsere globale Präsenz auszubauen und unsere marktführenden Dienstleistungen im Bereich Airline-Catering und Hospitality weiter zu verbessern.'
Mit der erwarteten Verbesserung des Unternehmensratings auf B2 (stabil) / B+ (stabil) durch Moody's bzw. S&P Global erhält gategroup einen verbesserten Zugang zu den internationalen Kapitalmärkten. Die Refinanzierung verbessert die Kapitalstruktur des Unternehmens erheblich und positioniert es für nachhaltiges Wachstum und Wertschöpfung.
Urs Schwendinger, Chief Financial Officer von gategroup, fügt hinzu: 'Wir sind äußerst zufrieden mit dem Ergebnis dieser Transaktion, die trotz volatiler Marktbedingungen mehrere nennenswerte Merkmale unter den nach der Ankündigung der US-Zölle lancierten Finanztransaktionen aufweist, darunter die größte grenzüberschreitende Term Loan B Emission, die größte Emission einer 'First Time' Emittentin und in ihrem Segment und Rating-Universum die größte Neugelddarlehens-Transaktion'
Für Medien- und Investorenanfragen wenden Sie sich bitte an:
IR@gategroup.com mediacontact@gategroup.com
Über gategroup gategroup ist der weltweit führende Anbieter von Airline-Catering, Retail-on-Board und Hospitality-Produkten und Dienstleistungen. Mit Hauptsitz in Zürich, Schweiz, betreibt gategroup über 200 Betriebe in mehr als 60 Ländern, die Passagieren auf allen Kontinenten kulinarische und einzelhandelsbezogene Spitzenleistungen bieten. Erfahren Sie mehr unter www.gategroup.com.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Aiper Launches Global Strategic Hub in Singapore Following USD 100 Million Strategic Investment from Fluidra
Aiper Launches Global Strategic Hub in Singapore Following USD 100 Million Strategic Investment from Fluidra

Yahoo

time31 minutes ago

  • Yahoo

Aiper Launches Global Strategic Hub in Singapore Following USD 100 Million Strategic Investment from Fluidra

SINGAPORE, May 30, 2025 /PRNewswire/ -- Aiper, a global leading player in cordless robotic pool cleaning, is celebrating the strategic partnership with Fluidra, a global leader in pool equipment and connected solutions in the pool and wellness sector. The USD 100 million investment marks the largest single funding deal in the global robotic pool cleaners to date and was commemorated at a signing ceremony held at Sofitel Singapore Sentosa Resort & Spa. Additionally, Singapore has been designated as Aiper's Global Strategic Hub, playing a central role in coordinating the company's international resources and operations. Already present in 45 countries and stocked in over 7,000 retail stores globally — Aiper has reached 2 million consumers worldwide. As the demand for smart, sustainable home living solutions grows, Aiper's vision to "Bring Vacation Home" is resonating with pool owners and homeowners alike. Leading the Way in AI Driven, Cordless Robotic Cleaning Globally This partnership launches Singapore as the key anchor of Aiper's Global Strategic Hub, from which the company will coordinate international operations and accelerate "Singapore+1" regional expansion strategy. By tapping into Singapore's strengths in geographic advantages, robust industrial infrastructure, and business-friendly environment, Aiper aims to scale its operations globally. Aiper's strategic investment of USD 100 million from Fluidra reflects a shared confidence in the company's vision and innovation capabilities. Amid ongoing strategic alignment, operational independence will be preserved and respective core strengths fully leveraged. The investment will further support Aiper's advancement in core technologies and accelerate the development of its smart backyard ecosystem. By leveraging their respective strengths, the two companies will work in close synergy across technology, brand development, and global service networks—advancing the pool cleaning industry and delivering enhanced value to customers worldwide. While continuing to deepen its presence in the pool cleaning sector and key markets such as North America and Europe, Aiper is accelerating its global expansion into high-potential regions including Asia-Pacific, the Middle East, and Latin America. In the Asia-Pacific region, Aiper has established a comprehensive operational ecosystem—including supply chain, customer service and branding. This ecosystem provides a strong platform for global growth and regional collaboration. At the signing ceremony, Richard Wang, Founder and CEO of Aiper, remarked: "The partnership between Aiper and Fluidra marks a win-win collaboration and a key milestone in Aiper's global expansion journey. Looking ahead, we will continue to drive progress in product innovation, brand influence, and global service capabilities—always placing user needs at the center. Our goal is to solve real-world cleaning challenges and empower customers to enjoy a truly smart, worry-free, and effortless outdoor living experience by leaving the hard work to Aiper." For more information about Aiper visit and follow Aiper on LinkedIn, Facebook, Instagram, TikTok, and X. About Aiper Aiper is the global pioneer of cordless robotic pool cleaning technology and a leader in smart yard product solutions. Through its "Bring Vacation Home" campaign, Aiper empowers homeowners to transform their backyards into a personal vacation retreat with the help of innovative, smarter, and greener product solutions that effortlessly handle pool and lawn maintenance to save time, money, and energy. From state-of-the-art pool cleaners to intelligent irrigation systems, Aiper delivers a comprehensive backyard ecosystem of products that simplify outdoor maintenance so users can enjoy more leisure and fun. Renowned for excellence, Aiper products have garnered prestigious awards, including the Red Dot Design Award, the iF Design Award, and editorial awards from USA Today and TWICE. Additionally, Aiper has been recognized as a CES Innovation Awards honoree in 2023, 2024, and 2025, underscoring its commitment to pioneering smart yard solutions. View original content to download multimedia: SOURCE Aiper

BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA")
BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA")

Yahoo

timean hour ago

  • Yahoo

BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA")

The APA Formalized the February 2024 BioVaxys Acquisition of the Former IMV Inc. Assets VANCOUVER, BC, May 29, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce today that the Company and Horizon Technology Finance Corporation ("Horizon") have executed a follow-on Amendment ("Amendment") to the Asset Purchase Agreement dated February 11th, 2024 ("APA") for acquiring the entire portfolio of assets and intellectual property based on the DPX™ immune educating platform technology developed by Canadian biotechnology company, IMV Inc. Section 12 of the February 11th, 2024 APA is a performance milestone provision for BioVaxys to demonstrate an aggregate capital raise of USD $10M by December 31, 2024. On December 9th, 2024, Horizon and BioVaxys initially amended the APA by agreeing to delete the reference to "December 31, 2024" found in Section 12 and replacing it with the date of "June 30, 2025." This new Amendment of May 29th, 2025, supersedes and replaces the Section 12 terms of the APA so that the net performance milestone required to be raised in any form (including, but not limited to equity, grants, licensing fees, or loans) is now significantly lowered to USD $2,028,636. If BioVaxys is successful in meeting this milestone by September 30, 2025, Section 12 of the APA shall end and be of no further force or effect. As consideration for Horizon amending the APA, BioVaxys agrees to issue to Horizon 2,800,000 share purchase warrants and 1,200,000 share purchase warrants to Powerscourt Investments XXV LP ("Powerscourt"), with each warrant entitling Horizon and Powercourt the purchase of one whole at a purchase price of $0.06 Canadian Dollars per share at any time on or before May 31, 2028. Horizon and Powerscourt are the members/owners of HIMV LLC (70%/30%), the party to the APA. All other terms and conditions of the APA to remain the same. BioVaxys and Horizon have further agreed that Section 7(c)(i) of the APA "Licensing Earn-Out Payments Term" be amended from the original "Eighth anniversary of the Closing Date" found in the last line of Section 7(c)(i) to August 11, 2033. During the Licensing Non-Sales Earn-Out Term, BioVaxys shares a predetermined percentage of net licensing non-sales revenues with Horizon. The "Licensing Non-Sales Earn-Out Term" refers to payments received from an existing licensee or preexisting potential licensee, ending upon the expiration of the last valid claim of a former IMV patent that is the subject of the license agreement to which such existing licensee or preexisting potential licensee is party, and any other payment received under a license agreement, ending on August 11, 2033. About BioVaxys Technology Corp. BioVaxys Technology Corp. ( is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on its DPX™ immune-educating technology platform and its HapTenix© 'neoantigen' tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization for food allergy, and other immunological diseases. Through a differentiated and unique mechanism of action, the DPX™ platform delivers instruction to the immune system to generate a specific, robust, and persistent immune response. The Company's clinical stage pipeline includes maveropepimut-S (MVP-S), based on the DPX™ platform, in Phase IIB clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant Ovarian Cancer. MVP-S delivers antigenic peptides from survivin, a well-recognized cancer antigen commonly overexpressed in advanced cancers, and also delivers an innate immune activator and a universal CD4 T cell helper peptide. MVP-S has been well tolerated and has demonstrated defined clinical benefit in multiple cancer indications as well as the activation of a targeted and sustained, survivin-specific anti-tumor immune response. BioVaxys is also developing DPX™+SurMAGE, a dual-targeted immunotherapy combining antigenic peptides for both the survivin and MAGE-A9 cancer proteins to elicit immune responses to these two distinct cancer antigens simultaneously, DPX™-RSV for Respiratory Syncytial Virus, and DPX+rPA for peanut allergy prophylaxis, as well as several viral vaccines. BioVaxys has licensed its patented liposome-based delivery platform to Zoetis, Inc. and SpayVac-for-Wildlife, Inc. for selected animal health applications. BioVaxys common shares are listed on the CSE under the stock symbol 'BIOV', trade on the Frankfurt Bourse (FRA: 5LB), and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn. ON BEHALF OF THE BOARD Signed "James Passin" James Passin, Chief Executive OfficerPhone: +1 740 358 0555 Cautionary Statements Regarding Forward Looking Information This press release includes certain "forward-looking information" and "forward-looking statements" (collectively "forward-looking statements") within the meaning of applicable Canadian and United States securities legislation including the United States Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, included herein, without limitation, statements relating the future operating or financial performance of the Company, are forward looking statements. Forward-looking statements are frequently, but not always, identified by words such as "expects", "anticipates", "believes", "intends", "estimates", "potential", "possible", and similar expressions, or statements that events, conditions, or results "will", "may", "could", or "should" occur or be achieved. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those expressed or implied in such forward-looking statements. These forward-looking statements reflect the beliefs, opinions and projections on the date the statements are made and are based upon a number of assumptions and estimates, primarily the assumption that BioVaxys will be successful in developing and testing vaccines, that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies including, primarily but without limitation, the risk that BioVaxys' vaccines will not prove to be effective and/ or will not receive the required regulatory approvals. With regards to BioVaxys' business, there are a number of risks that could affect the development of its biotechnology products, including, without limitation, the need for additional capital to fund clinical trials, its lack of operating history, uncertainty about whether its products will complete the long, complex and expensive clinical trial and regulatory approval process for approval of new drugs necessary for marketing approval, and, if so, whether its vaccine products will be commercially accepted and profitable, the expenses, delays and uncertainties and complications typically encountered by development stage biopharmaceutical businesses, financial and development obligations under license arrangements in order to protect its rights to its products and technologies, obtaining and protecting new intellectual property rights and avoiding infringement to third parties and their dependence on manufacturing by third parties. The Company does not assume any obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law. Investors are encouraged to read BioVaxys continuous disclosure documents and audited annual consolidated financial statements which are available on SEDAR at Logo - View original content to download multimedia: SOURCE BioVaxys Technology Corp. Sign in to access your portfolio

XRP, DOGE holders turn to APTMiner platform to earn passive income
XRP, DOGE holders turn to APTMiner platform to earn passive income

Business Upturn

time2 hours ago

  • Business Upturn

XRP, DOGE holders turn to APTMiner platform to earn passive income

Seattle, Washington , May 29, 2025 (GLOBE NEWSWIRE) — Friends of Dogecoin and Ripple start using APT Miner to earn passive income Recently, the price of coins has fluctuated greatly. Many friends who hold Dogecoin and Ripple do not want to pay attention to the market every day, so they start using APT Miner cloud mining. This platform has a low threshold, no need to buy equipment, and no complicated operations. You only need to buy contracts and wait for income every day. Compared with paying attention to price fluctuations, letting your cryptocurrency automatically help you make money is a truly worry-free and reliable choice. How to mine in the cloud: 1: Register now to get a $15 bonus (earn $0.6 by signing in daily) 2: Choose a contract: After successfully registering, the next step is to choose a mining contract that suits your goals and budget. APT Miner offers a variety of contracts to meet your different needs, whether you are a novice or an experienced miner. Take a close look at the available options and consider factors such as contract length, potential returns, and associated costs. Choose the right contract to start earning passive income, here is your potential earnings: 【New User Experience Contract】: Investment amount: US$100, total net profit: US$100 + US$8. 【DOGE(Gold Shell-Mini-DOGE-Pro)】: Investment amount: US$500, total net profit: US$500+US$42. 【BTC(Antminer-S19-XP)】: Investment amount: USD 2,500, total net profit: USD 2,500 + USD 437. 【BTC(Antminer-S19-XP)】: Investment amount: USD 7,500, total net profit: USD 7,500 + USD 3,375. 【BTC(AntminerT21)】: Investment amount: USD 17,000, total net profit: USD 17,000 + USD 9,520. 【BTC/BCH(ANTSPACE HK3)】:Investment amount: USD 50,000, total net profit: USD 50,000 + USD 35,600. More contract details: Visit APT Miner contract page for details: 3: Start to Profit: After selecting and activating the mining contract, you can sit back and relax while the system automatically completes your mining tasks. Working for you. APT Miner's advanced technology ensures that your mining operations run efficiently and maximizes your potential profits. As your mining activity progresses, profits will begin to accumulate in your account. You can track your mining performance through the platform dashboard and withdraw your earnings when you are ready. APT Miner platform advantages: 1: Cutting-edge equipment: Use mining equipment provided by top mining machine manufacturers such as Bitmain, Shenma Mining Machine, and Canaan Creative to ensure the stable operation and efficient production capacity of Bitcoin mining machines. 2: Legality and global users: The platform was legally established in the UK in 2018, protected and issued by the UK government, and has attracted more than 9 million real users around the world with cutting-edge technology. 3: Intuitive Interface: The platform's user-friendly interface ensures that even cryptocurrency newbies can easily get started. 4: Supports settlement of multiple popular cryptocurrencies: such as Dogecoin (DOGE), Bitcoin (BTC), Ethereum (ETH), US Dollar (USDC), US Dollar (USDT), Bitcoin Cash (BCH), Litecoin (LTC), etc. 5: Stable income: The contracts launched by the platform generate income every 24 hours, and the principal will be automatically returned after the contract expires. 6: APTMiner provides 7/24 hours customer service, supports global languages, and communication is barrier-free 7: Affiliate Program: You can refer friends and get a referral bonus of up to $50,000. For more details, please visit the official website: Official email: [email protected] Summarize: APT Miner is a company legally registered in the UK, engaged in network encryption technology services, authorized and regulated by the UK Financial Services Authority, and abides by local laws and regulations. Since its establishment in 2018, it has gained the trust of more than 9 million users. The company's mission is to make cloud mining accessible to everyone, providing the most advanced technology and large industrial data centers, which can be easily accessed from any device at any time and anywhere. Disclaimer: The information provided in this press release is not a solicitation to invest and is not intended as investment advice, financial advice, or trading advice. Cryptocurrency mining and staking involve risks. There is a possibility of loss of funds. You are strongly advised to perform due diligence before investing or trading in cryptocurrencies and securities, including consulting a professional financial advisor. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store